A Whiting-Turner Lecture:
How Advances in Medical Technology Will Provide Greater Value to Patients and the Health Care System

Art Collins, chairman and CEO of Medtronic, will deliver the final Whiting-Turner lecture of the spring semester. Lecture Date & Time: May 3, 2007, 5 p.m. Lecture preceded by reception at 4:30 p.m.

Abstract
Art Collins will discuss how advances in traditional medical technology are being combined with advances in information technology, biotechnology and other breakthroughs to improve medical outcomes as well as provide more cost-effective delivery of care around the world. He will characterize the environment in which these advances are being made and highlight specific examples of how technology is either extending life or improving the quality of life for an increasing number of people. He will also highlight factors that either enhance or hinder innovation within the medical technology industry, while discussing Medtronic's approach to address both the opportunities and issues that lie ahead.

Biography
Art Collins assumed the role of chief executive officer of Medtronic, Inc. in April 2001, and became chairman of the Board in April 2002. He was elected chief operating officer and member of the Board of Directors in 1994 and president in 1996. He joined the company in 1992 as corporate executive vice president and president of Medtronic International with responsibility for all Medtronic operations outside the United States.

Medtronic is the largest medical technology company in the world with revenues of over $11 billion in the most recent fiscal year. Doing business in more than 120 countries, Medtronic's employment currently exceeds 35,000. Every five seconds someone, somewhere in the world receives a Medtronic product that either significantly improves or saves their life.

Collins joined Medtronic from Abbott Laboratories where he had been corporate vice president with responsibility for Abbott's worldwide diagnostic business units since 1986. He began his 14-year career with Abbott in 1978 as manager of corporate planning and development and moved to the Diagnostics Division a year later where he subsequently held a number of general management positions in the United States and Europe. He was elected a corporate officer in 1989.

Collins received a Bachelor of Science degree in business administration and a Doctor of Laws honorary degree from Miami University in Oxford, Ohio. Collins also holds a Master of Business Administration Degree from the Wharton School of the University of Pennsylvania, where he was a member of the undergraduate faculty.

Students Welcome!

May 3, 2007
5 p.m.
1110 Kim Building

Visit the Whiting-Turner Lecture Series Homepage